Amoxicillin and Beta-Lactamase Inhibitor shortage in Italy

Is there an Amoxicillin and Beta-Lactamase Inhibitor shortage in Italy?

Yes. As of 2 Nov 2026, 9 Amoxicillin and Beta-Lactamase Inhibitor products are reported short in Italy, the first since 11 Mar 2022. The company estimate for the return is 31 Mar 2027. Main reason: increased demand.

Also short in Canada, Spain, Ireland, Switzerland, Czechia, Sweden. All countries.

Affected products in Italy

Country	Product	Company	Since	Expected back	Reason
IT	AMOXICILLINA E ACIDO CLAVULANICO ZENTIVA ITALIA	ZENTIVA ITALIA S.R.L.	11 Mar 2022	not given	Manufacturing problem Problemi produttivi: forniture discontinue
IT	AMOXICILLINA E ACIDO CLAVULANICO IBIGEN	IBIGEN S.R.L.	30 Mar 2022	not given	Increased demand Elevata richiesta: distribuzione contingentata
IT	SAROMOX	HEXAL A/S	9 Jun 2023	not given	Increased demand Elevata richiesta
IT	ABIOCLAV	S.F. GROUP S.R.L.	1 Jun 2025	not given	Manufacturing problem Problemi produttivi
IT	XINAMOD	PHARMACARE S.R.L.	1 Apr 2026	not given	Commercial decision or withdrawal Motivi commerciali
IT	POSMOX	PHARMACARE S.R.L.	1 Jun 2026	not given	Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail)
IT	AMOXICILLINA E ACIDO CLAVULANICO PENSA PHARMA	TOWA PHARMACEUTICAL S.P.A.	1 Jul 2026	31 Mar 2027	Increased demand Elevata richiesta
IT	AMOXICILLINA ACIDO CLAVULANICO TEVA	TEVA ITALIA S.R.L.	14 Aug 2026	not given	Increased demand Elevata richiesta
IT	AMOXICILLINA E ACIDO CLAVULANICO SANDOZ A/S anticipated discontinuation	SANDOZ A/S	14 Dec 2026	not given	Manufacturing problem Problemi produttivi: ridotta disponibilità

Source

AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.